메뉴 건너뛰기




Volumn 12, Issue 7 II, 2006, Pages

Sentinel lymph node biopsy and melanoma biology

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10;

EID: 33646234257     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2506     Document Type: Review
Times cited : (19)

References (17)
  • 1
    • 0032515763 scopus 로고    scopus 로고
    • Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial
    • Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. Lancet 1998;351:793-6.
    • (1998) Lancet , vol.351 , pp. 793-796
    • Cascinelli, N.1    Morabito, A.2    Santinami, M.3
  • 2
    • 0026590057 scopus 로고
    • Technical details of intraoperative lymphatic mapping for early-stage melanoma
    • Morton DL, Wen DR, Wong J, et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg 1992;127:392-9.
    • (1992) Arch Surg , vol.127 , pp. 392-399
    • Morton, D.L.1    Wen, D.R.2    Wong, J.3
  • 3
    • 0033958326 scopus 로고    scopus 로고
    • Standardized probe-directed sentinel node dissection in melanoma
    • Essner R, Bostick PJ, Glass EC, et al. Standardized probe-directed sentinel node dissection in melanoma. Surgery 2000;127:26-31.
    • (2000) Surgery , vol.127 , pp. 26-31
    • Essner, R.1    Bostick, P.J.2    Glass, E.C.3
  • 4
    • 4344657608 scopus 로고    scopus 로고
    • Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours
    • Cochran AJ, Roberts A, Wen DR, et al. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours. Pathology 2004;36:478-84.
    • (2004) Pathology , vol.36 , pp. 478-484
    • Cochran, A.J.1    Roberts, A.2    Wen, D.R.3
  • 5
    • 0032790889 scopus 로고    scopus 로고
    • Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma
    • Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999;5:442-9.
    • (1999) Ann Surg Oncol , vol.5 , pp. 442-449
    • Essner, R.1    Conforti, A.2    Kelley, M.C.3
  • 6
    • 0031800249 scopus 로고    scopus 로고
    • Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
    • Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
    • (1998) J Clin Oncol , vol.16 , pp. 2253-2260
    • Gershenwald, J.E.1    Colome, M.I.2    Lee, J.E.3
  • 7
    • 0033497863 scopus 로고    scopus 로고
    • Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial
    • Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg 1999;230:453-65.
    • (1999) Ann Surg , vol.230 , pp. 453-465
    • Morton, D.L.1    Thompson, J.F.2    Essner, R.3
  • 8
    • 24944441877 scopus 로고    scopus 로고
    • Sentinel node biopsy for early-stage melanoma. Accuracy and morbidity in MSLT-I, an international multicenter trial
    • Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma. Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302-13.
    • (2005) Ann Surg , vol.242 , pp. 302-313
    • Morton, D.L.1    Cochran, A.J.2    Thompson, J.F.3
  • 9
    • 24044509861 scopus 로고    scopus 로고
    • Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma
    • abstract 7500
    • Morton DL, Thompson JF, Cochran AJ, et al. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma [abstract 7500]. J Clin Oncol 2005;23:710S.
    • (2005) J Clin Oncol , vol.23
    • Morton, D.L.1    Thompson, J.F.2    Cochran, A.J.3
  • 10
    • 4344590283 scopus 로고    scopus 로고
    • Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients
    • Takeuchi H, Morton DL, Kuo C, et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol 2004;22:2671-80.
    • (2004) J Clin Oncol , vol.22 , pp. 2671-2680
    • Takeuchi, H.1    Morton, D.L.2    Kuo, C.3
  • 11
    • 4644309225 scopus 로고    scopus 로고
    • Factors predictive of tumor-positive non-sentinel lymph nodes after tumor-positive sentinel node dissection for melanoma
    • Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive non-sentinel lymph nodes after tumor-positive sentinel node dissection for melanoma. J Clin Oncol 2004;22:3677-84.
    • (2004) J Clin Oncol , vol.22 , pp. 3677-3684
    • Lee, J.H.1    Essner, R.2    Torisu-Itakura, H.3    Wanek, L.4    Wang, H.5    Morton, D.L.6
  • 12
    • 3042776109 scopus 로고    scopus 로고
    • Lessons learned from the Sunbelt Melanoma Trial
    • McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004;86:212-23.
    • (2004) J Surg Oncol , vol.86 , pp. 212-223
    • McMasters, K.M.1    Noyes, R.D.2    Reintgen, D.S.3
  • 13
    • 0034979375 scopus 로고    scopus 로고
    • Sentinel lymph nodes show profound down-regulation of antigen presenting cells of the paracortex: Implications for tumor biology and treatment
    • Cochran AJ, Morton DL, Stern S, et al. Sentinel lymph nodes show profound down-regulation of antigen presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 2001;16:604-8.
    • (2001) Mod Pathol , vol.16 , pp. 604-608
    • Cochran, A.J.1    Morton, D.L.2    Stern, S.3
  • 14
    • 10844242206 scopus 로고    scopus 로고
    • Lymphangiogenesis and cancer: Meeting report
    • Alitalo K, Mohia S, Ruosiahti E. Lymphangiogenesis and cancer: meeting report. Cancer Res 2004;64:9225-9.
    • (2004) Cancer Res , vol.64 , pp. 9225-9229
    • Alitalo, K.1    Mohia, S.2    Ruosiahti, E.3
  • 15
    • 0036358039 scopus 로고    scopus 로고
    • Dendritic cell function in sentinel nodes
    • Huningt.
    • Essner R, Kojima M. Dendritic cell function in sentinel nodes. Oncology (Huningt.) 2002;16:27-31.
    • (2002) Oncology , vol.16 , pp. 27-31
    • Essner, R.1    Kojima, M.2
  • 16
    • 11344249225 scopus 로고    scopus 로고
    • Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes
    • Lee JH, Torisu-Itakura H, Cochran AJ, et al. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res 2005;11:107-12.
    • (2005) Clin Cancer Res , vol.11 , pp. 107-112
    • Lee, J.H.1    Torisu-Itakura, H.2    Cochran, A.J.3
  • 17
    • 8544239395 scopus 로고    scopus 로고
    • Local administration of granulocyte-macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma
    • Vaylsteke RJCLM, Molenkamp BG, Giefema HA, et al. Local administration of granulocyte-macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma. Cancer Res 2004;64:8456-60.
    • (2004) Cancer Res , vol.64 , pp. 8456-8460
    • Vaylsteke, R.J.C.L.M.1    Molenkamp, B.G.2    Giefema, H.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.